Vemlidy (generic name: tenofovir alafenamide) is an antiviral medication used to treat long-lasting hepatitis B virus (HBV) infection.
It can be prescribed for adults and children aged 6 years and older who weigh at least 25 kg and have compensated liver disease. Tenofovir alafenamide belongs to the class of medications known as nucleotide reverse transcriptase inhibitors (NtRTIs), which work by inhibiting the replication of the hepatitis B virus, thereby reducing the amount of virus in the body and improving liver function.
Dosage
It is important to take Vemlidy exactly as prescribed by your healthcare provider. Do not miss any doses, as this can reduce the effectiveness of the treatment.
The recommended dosage of Vemlidy for adults and pediatric patients aged 6 years and older weighing at least 25 kg is one 25 mg tablet taken orally once daily with food.
If a dose is missed and it is less than 12 hours from the usual time, take it as soon as possible. If more than 12 hours have passed, skip the missed dose and resume the regular dosing schedule. Do not double-dose to make up for a missed dose.
Storage
Store Vemlidy tablets at room temperature, between 20°C to 25°C (68°F to 77°F). Keep the medication in its original container, tightly closed, and protect it from moisture.
Do not store Vemlidy in the bathroom. Keep out of reach of children and pets.
Common Questions About Vemlidy
How should I take Vemlidy?
Take Vemlidy exactly as prescribed by your healthcare provider. The usual dose is one tablet once daily with food. Do not miss doses, and do not take more than the recommended amount.
Is tenofovir alafenamide safe during pregnancy?
If you are pregnant or planning to become pregnant, discuss with your healthcare provider the potential risks and benefits of using tenofovir alafenamide during pregnancy.
What is chronic hepatitis B, and how does Vemlidy help?
Chronic hepatitis B is a long-term liver infection caused by the hepatitis B virus. Vemlidy helps by reducing the amount of virus in the body, which can improve liver function and reduce the risk of complications.
This text is for informational purposes only. Please consult a doctor or pharmacist before using any medication.
Read the information leaflet that comes with the medication.
Most people who use Vemlidy do not experience any adverse side effects. Doctors prescribe this medication because they assess the benefits of such treatment outweigh any likely unwanted effects.
Some of the side effects that have been reported include headaches, abdominal pain, fatigue, cough, nausea, and back pain. In some cases, Vemlidy may cause serious side effects, including new or worsening kidney problems and high levels of lactic acid in the blood (lactic acidosis). If the use of the medication is discontinued without first referring to a doctor, it can lead to the worsening of hepatitis B infection.
Not all side effects are listed here. If these or other unlisted symptoms persist or worsen, consult a healthcare provider or pharmacist.
Vemlidy is indicated specifically for the treatment of chronic hepatitis B virus (HBV) infection in patients with compensated liver disease. Chronic hepatitis B is a long-term infection of the liver caused by the hepatitis B virus, which can lead to serious liver damage, including cirrhosis and liver cancer, if left untreated. By reducing the amount of virus in the body, Vemlidy helps to manage the infection and prevent complications associated with chronic hepatitis B.
It is important to have regular check-ups with your healthcare provider to monitor your health during treatment.